Stock Analysis on Net
Stock Analysis on Net

Cigna Group (NYSE:CI)

This company has been moved to the archive! The financial data has not been updated since February 27, 2025.

Common-Size Income Statement
Quarterly Data

Cigna Group, common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Pharmacy revenues 76.40 75.91 74.92 73.79 72.02 70.87 70.31 69.52 72.76 72.68 70.81 70.42 71.35 70.77 70.17 69.06 68.47 68.38 68.04 65.85
Premiums 17.60 17.98 19.03 20.37 21.99 22.57 22.85 23.84 20.96 21.27 23.09 23.76 22.83 23.45 24.11 25.17 25.88 26.27 26.65 28.44
Fees and other revenues 6.01 6.11 6.06 5.84 5.99 6.56 6.84 6.64 6.27 6.05 6.11 5.82 5.82 5.78 5.72 5.77 5.65 5.35 5.31 5.71
Revenues from external customers 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Pharmacy and other service costs -74.99 -74.78 -73.90 -72.73 -69.38 -69.04 -69.23 -68.03 -70.48 -70.50 -68.98 -68.39 -68.97 -68.62 -67.73 -67.11 -65.45 -65.48 -65.60 -63.46
Medical costs and other benefit expenses -15.55 -14.98 -15.81 -16.57 -18.26 -18.32 -18.70 -19.56 -17.55 -17.20 -18.14 -18.97 -19.30 -19.01 -19.81 -19.73 -21.40 -20.73 -18.22 -21.83
Gross profit 9.46% 10.25% 10.29% 10.70% 12.36% 12.64% 12.07% 12.40% 11.97% 12.30% 12.87% 12.64% 11.74% 12.37% 12.46% 13.16% 13.15% 13.79% 16.19% 14.70%
Net investment income 0.42 0.13 0.53 0.51 0.57 0.66 0.58 0.60 0.47 0.45 0.72 0.95 0.84 1.07 0.72 0.96 0.90 0.73 0.57 0.93
Selling, general and administrative expenses -5.91 -5.64 -6.12 -6.50 -7.99 -7.77 -7.11 -7.65 -7.65 -6.98 -7.21 -7.57 -8.08 -7.06 -7.00 -8.08 -9.59 -8.12 -8.73 -8.91
Amortization of acquired intangible assets -0.65 -0.69 -0.70 -0.74 -0.89 -0.93 -0.94 -0.99 -1.00 -1.02 -1.11 -1.05 -1.10 -1.14 -1.17 -1.22 -1.20 -1.21 -1.27 -1.31
Income from operations 3.32% 4.05% 4.01% 3.96% 4.05% 4.60% 4.60% 4.36% 3.79% 4.75% 5.27% 4.97% 3.39% 5.24% 5.01% 4.82% 3.25% 5.18% 6.76% 5.41%
Interest expense and other -0.55 -0.59 -0.62 -0.57 -0.71 -0.75 -0.75 -0.77 -0.71 -0.67 -0.67 -0.69 -0.65 -0.69 -0.70 -0.77 -0.82 -0.83 -0.96 -1.03
Debt extinguishment costs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.02 -0.32 0.00 0.00 -0.04 -0.49
Gain (loss) on sale of businesses 0.20 -0.14 0.00 -0.03 -2.91 -0.04 0.00 0.00 -0.16 3.85 0.00 0.00 0.00 0.00 0.00 0.00 10.17 0.00 0.00 0.00
Net realized investment gains (losses) 0.10 -1.45 -0.08 -3.22 -0.07 -0.03 0.05 -0.12 0.00 -0.18 -0.21 -0.73 0.15 0.16 0.14 0.00 0.40 0.08 0.10 -0.23
Income before income taxes 3.07% 1.87% 3.30% 0.14% 0.37% 3.78% 3.90% 3.46% 2.92% 7.74% 4.40% 3.55% 2.90% 4.70% 4.43% 3.73% 13.01% 4.44% 5.86% 3.67%
Income taxes -0.72 -0.58 -0.60 -0.51 1.81 -0.80 -0.77 -0.64 -0.29 -1.58 -0.91 -0.81 -0.40 -0.97 -0.99 -0.84 -2.99 -1.00 -1.35 -0.55
Net income (loss) 2.35% 1.30% 2.71% -0.37% 2.18% 2.97% 3.13% 2.82% 2.63% 6.16% 3.48% 2.75% 2.50% 3.73% 3.45% 2.89% 10.02% 3.44% 4.51% 3.12%
Net income attributable to noncontrolling interests -0.17 -0.14 -0.13 -0.11 -0.15 -0.08 -0.10 -0.08 -0.06 -0.05 -0.03 -0.03 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02
Shareholders’ net income (loss) 2.18% 1.16% 2.57% -0.49% 2.02% 2.89% 3.02% 2.74% 2.57% 6.12% 3.45% 2.71% 2.46% 3.70% 3.43% 2.86% 10.00% 3.41% 4.49% 3.10%

Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Income statement item Description The company
Income from operations The net result for the period of deducting operating expenses from operating revenues. Cigna Group income from operations as a percentage of revenues from external customers increased from Q2 2024 to Q3 2024 but then decreased significantly from Q3 2024 to Q4 2024.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Cigna Group income before income taxes as a percentage of revenues from external customers decreased from Q2 2024 to Q3 2024 but then increased from Q3 2024 to Q4 2024 not reaching Q2 2024 level.
Shareholders’ net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Cigna Group shareholders’ net income (loss) as a percentage of revenues from external customers decreased from Q2 2024 to Q3 2024 but then increased from Q3 2024 to Q4 2024 not reaching Q2 2024 level.